About Us

OncoFusion Therapeutics was founded in 2012 by two highly successful Endowed Professors Arul M. Chinnaiyan, M.D., Ph.D., and Shaomeng Wang, Ph.D., at the University of Michigan Medical School. OncoFusion also has an experienced leadership team that has been responsible for significant scientific advances combined with sound management.

Our mission is to discover and develop the next generation of personalized therapeutics for patients with genetically defined cancers.